Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: A Comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin
- 31 July 1982
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 73 (1) , 89-96
- https://doi.org/10.1016/0002-9343(82)90935-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Piperacillin or ticarcillin plus amikacinThe American Journal of Medicine, 1981
- Antibiotic combination-associated nephrotoxicity in granulocytopenic patients with cancerArchives of internal medicine (1960), 1981
- Improved prognosis for granulocytopenic patients with gram-negative bacteremiaThe American Journal of Medicine, 1980
- Antibacterial Activity of a New 1-Oxa Cephalosporin Compared with That of Other β-Lactam CompoundsAntimicrobial Agents and Chemotherapy, 1979
- Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancerThe American Journal of Medicine, 1979
- Three Antibiotic Regimens in the Treatment of Infection in Febrile Granulocytopenic Patients with CancerThe Journal of Infectious Diseases, 1978
- Therapy of Infection in Patients with GranulocytopeniaMedical Clinics of North America, 1977
- Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patientsThe American Journal of Medicine, 1977
- Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative InfectionsAntimicrobial Agents and Chemotherapy, 1972
- Gentamicin: Clinical Use with Carbenicillin and In-Vitro Studies with Recent Isolates of Pseudomonas aeruginosaThe Journal of Infectious Diseases, 1971